Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01746407 · ClinicalTrials.gov registry record
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
A clinical trial, sponsored by Abbott Diagnostics Division.
- Completed
- Registry status
- 872
- Enrollment target
NCT01746407: Completed study, sponsored by Abbott Diagnostics Division.
NCT01746407 is a clinical trial that has completed, run by Abbott Diagnostics Division. The registered enrollment target is 872 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01746407 has completed, sponsored by Abbott Diagnostics Division.
- COMPLETED
- Registry status
- 872 participants
- Enrollment target
Study Summary
Procure blood specimens from individuals presenting to the emergency department (ED) with signs and /or symptoms of systemic infection or sepsis. The samples will be used for research and development activities related to sepsis, infections, etc.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 872 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01746407
The ClinicalTrials.gov registry entry for NCT01746407 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 872 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diagnostics Division, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01746407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01746407 about?
NCT01746407 is a clinical study titled "Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis". Procure blood specimens from individuals presenting to the emergency department (ED) with signs and /or symptoms of systemic infection or sepsis. The samples will be used for research and development activities related to sepsis, infections, etc.
What is the current status of trial NCT01746407?
This trial is currently completed. The enrollment target is 872 participants. The study started on 2012-12. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01746407?
This trial is sponsored by Abbott Diagnostics Division, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.